Anita D'Souza, MD, discusses an abstract looking at the combination of teclistamab-cqyv, daratumumab, and pomalidomide in 2 ...

Study of frail older adult patients with myeloma showed reduced disease progression and death with a regimen reducing dexamethasone exposure.

Although it was receiving revenue from eight products, royalties from Johnson & Johnson (JNJ) subsidiary Janssen’s ...

The Institute for Clinical and Economic Review (ICER) has published its annual report on "unsupported" price increases for ...

In a report released on December 10, Alistair Campbell from RBC Capital maintained a Buy rating on Genmab A/S (0MGB – Research Report), with a ...